Related references
Note: Only part of the references are listed.Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
Senta Frol et al.
FRONTIERS IN NEUROLOGY (2021)
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge et al.
EUROPEAN STROKE JOURNAL (2021)
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases
Pawel Kermer et al.
INTERNATIONAL JOURNAL OF STROKE (2020)
Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review
David Giannandrea et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
David J. Seiffge et al.
LANCET NEUROLOGY (2019)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants
E. Touze et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
H. C. Diener et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Jennifer A. Frontera et al.
NEUROCRITICAL CARE (2016)
Idarucizumab The Antidote for Reversal of Dabigatran
John W. Eikelboom et al.
CIRCULATION (2015)
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
Joanna M. Wardlaw et al.
LANCET NEUROLOGY (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
A specific antidote for dabigatran: functional and structural characterization
Felix Schiele et al.
BLOOD (2013)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
